Barclays’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$558K Sell
80,809
-110,227
-58% -$850K ﹤0.01% 3133
2025
Q4
$1.68M Sell
191,036
-31,543
-14% -$174K ﹤0.01% 3055
2025
Q3
$1.11M Sell
222,579
-1,825
-0.8% -$8.45K ﹤0.01% 3298
2025
Q2
$1.06M Buy
224,404
+56,311
+33% +$246K ﹤0.01% 3303
2025
Q1
$772K Sell
168,093
-10,275
-6% -$47.9K ﹤0.01% 3264
2024
Q4
$854K Buy
178,368
+24,071
+16% +$116K ﹤0.01% 3474
2024
Q3
$724K Buy
154,297
+86,677
+128% +$465K ﹤0.01% 3559
2024
Q2
$382K Sell
67,620
-58,056
-46% -$300K ﹤0.01% 3210
2024
Q1
$517K Sell
125,676
-45,962
-27% -$184K ﹤0.01% 3570
2023
Q4
$724K Buy
171,638
+43,308
+34% +$175K ﹤0.01% 3658
2023
Q3
$554K Buy
128,330
+3,265
+3% +$18.1K ﹤0.01% 2733
2023
Q2
$824K Buy
125,065
+24,771
+25% +$159K ﹤0.01% 2429
2023
Q1
$681K Buy
100,294
+3,550
+4% +$25K ﹤0.01% 3035
2022
Q4
$715K Sell
96,744
-2,558
-3% -$24.9K ﹤0.01% 3059
2022
Q3
$981K Buy
99,302
+81,044
+444% +$856K ﹤0.01% 2252
2022
Q2
$199K Sell
18,258
-26,511
-59% -$275K ﹤0.01% 3424
2022
Q1
$507K Sell
44,769
-26,872
-38% -$353K ﹤0.01% 2901
2021
Q4
$1.12M Buy
71,641
+14,839
+26% +$259K ﹤0.01% 2756
2021
Q3
$974K Buy
56,802
+22,912
+68% +$401K ﹤0.01% 2803
2021
Q2
$729K Sell
33,890
-63,808
-65% -$1.14M ﹤0.01% 2854
2021
Q1
$1.47M Buy
97,698
+15,309
+19% +$248K ﹤0.01% 2525
2020
Q4
$1.08M Sell
82,389
-24,920
-23% -$300K ﹤0.01% 2700
2020
Q3
$1.03M Buy
107,309
+10,270
+11% +$110K ﹤0.01% 2661
2020
Q2
$1.11M Buy
97,039
+23,690
+32% +$268K ﹤0.01% 2662
2020
Q1
$760K Sell
73,349
-16,442
-18% -$204K ﹤0.01% 3233
2019
Q4
$1.47M Buy
89,791
+14,215
+19% +$215K ﹤0.01% 3302
2019
Q3
$1M Sell
75,576
-15,041
-17% -$210K ﹤0.01% 3665
2019
Q2
$1.28M Buy
90,617
+23,128
+34% +$368K ﹤0.01% 3433
2019
Q1
$1.24M Buy
67,489
+43,754
+184% +$997K ﹤0.01% 3164
2018
Q4
$620K Sell
23,735
-41,497
-64% -$976K ﹤0.01% 3606
2018
Q3
$1.5M Buy
65,232
+58,631
+888% +$1.2M ﹤0.01% 3229
2018
Q2
$126K Sell
6,601
-18,147
-73% -$303K ﹤0.01% 5084
2018
Q1
$417K Buy
24,748
+11,900
+93% +$199K ﹤0.01% 4153
2017
Q4
$195K Sell
12,848
-36,940
-74% -$548K ﹤0.01% 4715
2017
Q3
$891K Buy
49,788
+30,366
+156% +$508K ﹤0.01% 3102
2017
Q2
$318K Sell
19,422
-20,507
-51% -$296K ﹤0.01% 3944
2017
Q1
$559K Buy
39,929
+23,135
+138% +$330K ﹤0.01% 3293
2016
Q4
$267K Sell
16,794
-7,264
-30% -$117K ﹤0.01% 3963
2016
Q3
$401K Buy
24,058
+15,599
+184% +$210K ﹤0.01% 3405
2016
Q2
$95K Buy
8,459
+3,972
+89% +$38.5K ﹤0.01% 4439
2016
Q1
$36K Sell
4,487
-4,901
-52% -$40.2K ﹤0.01% 4952
2015
Q4
$84K Sell
9,388
-16,283
-63% -$162K ﹤0.01% 4519
2015
Q3
$282K Sell
25,671
-97
-0.4% -$1.19K ﹤0.01% 3845
2015
Q2
$310K Buy
25,768
+8,616
+50% +$92.9K ﹤0.01% 3849
2015
Q1
$154K Sell
17,152
-219,000
-93% -$2.47M ﹤0.01% 4539
2014
Q4
$3.31M Buy
236,152
+234,002
+10,884% +$2.77M 0.01% 2070
2014
Q3
$23K Sell
2,150
-30,707
-93% -$402K ﹤0.01% 6406
2014
Q2
$526K Buy
32,857
+4,088
+14% +$54.4K ﹤0.01% 3930
2014
Q1
$461K Sell
28,769
-299,569
-91% -$4.26M ﹤0.01% 4041
2013
Q4
$3.94M Buy
328,338
+284,142
+643% +$2.85M 0.01% 2024
2013
Q3
$442K Buy
44,196
+34,767
+369% +$371K ﹤0.01% 4251
2013
Q2
$76K Buy
+9,429
New +$63.5K ﹤0.01% 6016

Other funds holding VNDA